GB9920710D0 - Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity, - Google Patents

Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity,

Info

Publication number
GB9920710D0
GB9920710D0 GBGB9920710.2A GB9920710A GB9920710D0 GB 9920710 D0 GB9920710 D0 GB 9920710D0 GB 9920710 A GB9920710 A GB 9920710A GB 9920710 D0 GB9920710 D0 GB 9920710D0
Authority
GB
United Kingdom
Prior art keywords
antitumour
strenthening
acivity
composition containing
strengthening method
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9920710.2A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB9920710D0 publication Critical patent/GB9920710D0/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
GBGB9920710.2A 1998-09-17 1999-09-03 Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity, Ceased GB9920710D0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP26375398 1998-09-17
JP10323374A JP2000159682A (ja) 1998-09-17 1998-11-13 生薬の抗腫瘍活性強化方法、抗腫瘍活性強化生薬含有組成物、生薬処理の抗腫瘍有効性評価方法、および生薬の抗腫瘍有効性評価方法

Publications (1)

Publication Number Publication Date
GB9920710D0 true GB9920710D0 (en) 1999-11-03

Family

ID=26546176

Family Applications (2)

Application Number Title Priority Date Filing Date
GBGB9920710.2A Ceased GB9920710D0 (en) 1998-09-17 1999-09-03 Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity,
GB9921387A Withdrawn GB2341800A (en) 1998-09-17 1999-09-13 Activating antitumour polysaccharide drugs

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB9921387A Withdrawn GB2341800A (en) 1998-09-17 1999-09-13 Activating antitumour polysaccharide drugs

Country Status (19)

Country Link
JP (1) JP2000159682A ( )
KR (1) KR20000023206A ( )
CN (1) CN1255376A ( )
AU (1) AU4486299A ( )
BE (1) BE1012725A5 ( )
CA (1) CA2282234A1 ( )
DE (1) DE19944695A1 ( )
DK (1) DK199901235A ( )
ES (1) ES2155802B1 ( )
FR (2) FR2783426A1 ( )
GB (2) GB9920710D0 ( )
ID (1) ID23150A ( )
IL (1) IL131722A0 ( )
IS (1) IS5183A ( )
IT (1) IT1307267B1 ( )
NL (2) NL1013049C2 ( )
NO (1) NO994463L ( )
SE (2) SE9903307L ( )
SG (1) SG76631A1 ( )

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20090057480A (ko) * 2001-04-27 2009-06-05 아지노모토 가부시키가이샤 면역강화제
EP1385970A4 (en) * 2001-05-07 2004-11-24 Biohub Co Ltd PROCESS FOR THE PREPARATION OF LACTIC FERMENTATION SOLUTION BASED ON FUNGUS AND SOLUTION THUS OBTAINED
JP4499979B2 (ja) * 2001-05-21 2010-07-14 コンビ株式会社 病原菌感染抑制用組成物
WO2002098440A1 (fr) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Traitement antidiabetique
JP4826696B2 (ja) * 2003-04-07 2011-11-30 ビーエイチエヌ株式会社 血管新生阻害剤
JP4681801B2 (ja) * 2002-05-15 2011-05-11 ビーエイチエヌ株式会社 血管新生阻害剤およびその製造方法
KR100971599B1 (ko) 2002-05-15 2010-07-20 비에이취엔 가부시끼가이샤 혈관 관련 질환의 예방 또는 치료를 위한 조성물
JP2005089417A (ja) * 2003-09-19 2005-04-07 Noevir Co Ltd 糖尿病予防・治療用組成物
JP4587441B2 (ja) * 2004-02-12 2010-11-24 株式会社クレハ 新規な糖尿病治療剤および食品
KR20070041786A (ko) * 2004-09-17 2007-04-19 카부시키카이샤 에스·에스·아이 유방암을 억제하는 아가리쿠스 추출물
JP2006273835A (ja) * 2005-03-04 2006-10-12 Michishi Tani 悪性腫瘍治療剤及びそれを含む飲食品
WO2011014729A1 (en) * 2009-07-31 2011-02-03 Yukiguni Maitake Co., Ltd. Maitake mushroom coffee
WO2011081024A1 (ja) * 2009-12-29 2011-07-07 株式会社富士見養蜂園 旨味食品及びその製造方法
CN106333969A (zh) * 2016-08-30 2017-01-18 青海民族大学 圆孢蘑菇抑制hdac1酶有效部位及制法和应用
CN106309511A (zh) * 2016-08-30 2017-01-11 青海民族大学 圆孢蘑菇抑制cdc25酶有效部位及制法和应用
WO2019104579A1 (en) * 2017-11-30 2019-06-06 SHIEH, Darbin Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102602787B1 (ko) * 2020-12-16 2023-11-17 대한민국 꽃송이버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102646421B1 (ko) * 2020-12-16 2024-03-12 대한민국 잎새버섯 생리활성성분 및 영양성분의 함량을 증가시키는 방법
KR102584680B1 (ko) * 2020-12-17 2023-10-06 대한민국 생리활성 및 영양성분이 증가된 표고버섯차 제조방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5276413A (en) * 1975-12-18 1977-06-27 Kureha Chem Ind Co Ltd Production of oncostatic substances
US4177108A (en) * 1977-03-02 1979-12-04 Tetsuro Ikekawa Process for producing emitanin
DE2842691A1 (de) * 1978-09-30 1980-04-10 Karl Dr Med Theurer Energetische anregung biologischer arzneimittel
JPS57206618A (en) * 1981-06-12 1982-12-18 Noda Shiyokukin Kogyo Kk Preparation of antitumor substance
JPH02203765A (ja) * 1989-02-02 1990-08-13 Nippon Beet Sugar Mfg Co Ltd 抗腫瘍機能を有する食品及びその製造法
JP3357383B2 (ja) * 1991-08-14 2002-12-16 昌宏 黒田 低分子化植物性組成物
JP2955126B2 (ja) * 1992-06-22 1999-10-04 笑代 丹羽 医薬用油性製剤、食品用油性製剤およびそれらの製造方法
US6015913A (en) * 1996-09-06 2000-01-18 Mars, Incorporated Method for producing fat and/or solids from cocoa beans

Also Published As

Publication number Publication date
ID23150A (id) 2000-03-23
NL1013049C2 (nl) 2002-01-11
NO994463L (no) 2000-03-20
ES2155802B1 (es) 2001-12-01
ITTO990784A0 (it) 1999-09-14
NO994463D0 (no) 1999-09-15
DK199901235A (da) 2000-03-18
CA2282234A1 (en) 2000-03-17
ES2155802A1 (es) 2001-05-16
DE19944695A1 (de) 2000-03-30
SE9903307D0 (sv) 1999-09-16
SE9903307L (sv) 2000-03-18
KR20000023206A (ko) 2000-04-25
CN1255376A (zh) 2000-06-07
AU4486299A (en) 2000-03-30
ITTO990784A1 (it) 2001-03-14
NL1013049A1 (nl) 2000-03-21
IS5183A (is) 2000-03-17
FR2783426A1 (fr) 2000-03-24
JP2000159682A (ja) 2000-06-13
NL1019705A1 (nl) 2002-01-29
SE0100195D0 (sv) 2001-01-24
FR2788697A1 (fr) 2000-07-28
GB2341800A (en) 2000-03-29
IT1307267B1 (it) 2001-10-30
BE1012725A5 (fr) 2001-02-06
SG76631A1 (en) 2000-11-21
SE0100195L (sv) 2001-01-24
GB9921387D0 (en) 1999-11-10
NL1019705C2 (nl) 2002-03-26
IL131722A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
GB9920710D0 (en) Antitumour activity strengthening method of crude drugs,composition containing crude drug strenthening antitumour acivity,
HUP0002842A3 (en) Substituted imidazoles, process for producing them, pharmaceutical compositions containing them, their use and their intermediates
HUP0103622A3 (en) Non-peptide gnrh agents, methods and intermediates for their preparation and medicaments containing them
HK1028769A1 (en) 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
ZA989744B (en) Method for administering acylated insulin.
AU7051000A (en) Method of activity based costing
HUP0103542A3 (en) 4,4-biarylpiperidine derivatives with opioid receptor activity and pharmaceutical compositions containing them
HU0103988D0 (en) New compounds with pharmaceutical activity
IT1307266B1 (it) Apparecchio per infusione di farmaci.
PL321253A1 (en) Novel aromatic compounds, method of obtaining them, their application as drugs and pharmaceutic agent containing them
CZ20011652A3 (cs) Farmaceutický přípravek zahrnující moxifloxacin, způsob výroby a použití tohoto přípravku
IL148870A (en) 2'-substituted 1,1'-biphenyl - 2 - carbonamides, method for the production thereof, use thereof as medicament and pharmaceutical preparations containing said compounds
PL338143A1 (en) Derivatives acylpiperazinylpyrimidines, method of obtaining and drugs containing them
HUP0203524A3 (en) 2-(1h-indol-3-yl)-2-oxo-acetamides with antitumor activity, their use and pharmaceutical compositions containing them
HU9901526D0 (en) Pharmaceutical intermediates and process for producing them
HUP0103387A3 (en) Quinazoline derivatives preparation thereof, medicament containing them and their intermediates
HUP0200778A3 (en) Novel ribose-substituted aromatic amides, method for the production and use thereof as medicaments and their intermediates
HUP9800373A3 (en) Steroide compounds of anticeptive and antiosteoporosive activity, process for producing them and pharmaceutical compositions containing the same
HU9802716D0 (en) Pharmaceutical composition of analgesic activity
AU4417000A (en) Novel pharmaceutical composition suitable for gene therapy
HUP0200376A3 (en) Thiaoloindolinone compounds, process for their preparation and pharmaceutical composions containing them and their use
HUP0200993A3 (en) Thio-oxindole derivatives, use of them for producing pharmaceutical compositions and pharmaceutical compositions containing them
HUP0103665A3 (en) Isoquinolines as urokinase inhibitors, peocess for their preparation and medicaments containing them
ZA995910B (en) Antitumor activity strengthening method of crude drugs, and composition containing crude drug strengthening antitumor activity.
HUP0003647A3 (en) Bisethers of 1-oxa, aza and thianaphthalen-2-ones, their use for producing medicaments, the medicaments and their intermediates

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)